Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.15 trillion and total revenue of $111.47 billion.
Market Cap
1.15T
Revenue
111.47B
Profits
-41.06B
PE Ratio
n/a
Profit Margin
-36.84%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.78B | 3.01% | 1,398,283 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.60B | 1.49% | 824,536 | 14.92B |
| 3 | ARGX | argenx SE | 50.91B | -0.06% | 346,238 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.99B | 2.52% | 826,074 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.03B | 1.39% | 268,357 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.98B | 1.09% | 1,422,621 | - |
| 7 | RPRX | Royalty Pharma plc | 29.77B | 0.10% | 3,456,784 | 2.44B |
| 8 | INSM | Insmed Incorporated | 25.14B | 11.66% | 8,274,773 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.69B | 0.34% | 384,790 | 3.23B |
| 10 | MRNA | Moderna, Inc. | 21.14B | 0.74% | 11,248,182 | 2.23B |
| 11 | ROIV | Roivant Sciences Ltd. | 21.03B | 1.48% | 8,436,991 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.80B | -1.19% | 1,577,441 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.50B | 3.48% | 2,243,947 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.76B | -0.43% | 879,685 | 998.25M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.71B | 1.55% | 2,238,440 | - |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.30B | 1.89% | 807,774 | 4.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.92B | 1.96% | 2,409,937 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.53B | 0.60% | 1,408,863 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.43B | -0.50% | 2,766,761 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | 2.66% | 235,015 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.53B | 3.49% | 633,132 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 1.67% | 1,544,470 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.22B | 0.57% | 1,205,270 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.63B | -0.61% | 734,477 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | 3.43% | 426,105 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.31B | 0.34% | 2,418,512 | 105.82M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.15B | -0.82% | 316,250 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.50B | 0.12% | 9,900,490 | 140.98M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.41B | 6.81% | 4,874,519 | 1.51B |
| 30 | NUVL | Nuvalent, Inc. | 8.10B | -1.92% | 673,853 | - |
| 31 | PCVX | Vaxcyte, Inc. | 7.80B | 0.07% | 1,260,710 | - |
| 32 | TECH | Bio-Techne Corporation | 7.43B | 0.01% | 1,767,173 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.87B | -0.65% | 385,165 | 51.48M |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.52B | 0.67% | 662,806 | 569.61M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.52B | -1.82% | 1,760,535 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.43B | -3.43% | 645,705 | 74.06M |
| 37 | CGON | CG Oncology, Inc. | 6.36B | 3.97% | 1,644,599 | 5.07M |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.26B | 4.49% | 655,396 | 217.17M |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.22B | -2.38% | 2,212,245 | 827.11M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.22B | -1.97% | 497,173 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 1,524,360 | 15.00M |
| 42 | BLTE | Belite Bio, Inc | 6.12B | 2.35% | 87,196 | - |
| 43 | TGTX | TG Therapeutics, Inc. | 6.03B | -1.39% | 2,382,780 | 700.35M |
| 44 | CELC | Celcuity Inc. | 6.03B | -0.76% | 1,175,505 | - |
| 45 | COGT | Cogent Biosciences, Inc. | 5.90B | 1.26% | 1,187,158 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.89B | 1.74% | 1,318,659 | - |
| 47 | IMVT | Immunovant, Inc. | 5.83B | -1.41% | 1,145,132 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.49B | -0.08% | 771,273 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.32B | -1.40% | 789,661 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.26B | 0.10% | 7,931,662 | 1.11B |
| 51 | LEGN | Legend Biotech Corporation | 5.23B | 10.48% | 5,050,401 | 1.03B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.10B | -2.18% | 971,748 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.74B | 5.14% | 3,278,572 | 907.29M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | -1.11% | 347,128 | 1.34M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.47B | -1.77% | 2,146,823 | 22.57M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | 0.69% | 164,216 | 274.48M |
| 57 | MANE | Veradermics, Incorporated | 4.28B | -3.91% | 560,485 | - |
| 58 | TVTX | Travere Therapeutics, Inc. | 3.98B | -1.54% | 1,763,986 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | 0.98% | 1,331,657 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.87B | -1.57% | 1,088,250 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | -0.03% | 3,354,099 | 596.96M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -0.37% | 1,125,155 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | -1.59% | 1,168,380 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.64B | -1.26% | 1,328,511 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.53B | -4.06% | 133,879 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.39B | 0.09% | 1,387,823 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.23B | -0.57% | 3,763,972 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.14B | -0.54% | 1,438,670 | 164.01M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.13B | 0.16% | 691,073 | 236.00M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.09B | -1.07% | 1,792,298 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.04B | -0.49% | 846,681 | - |
| 72 | ALMS | Alumis Inc. | 2.99B | -0.63% | 602,344 | 24.05M |
| 73 | KLRA | Kailera Therapeutics, Inc. | 2.89B | -2.75% | 359,206 | - |
| 74 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.02% | 1,775,897 | 285.01M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.69B | -1.25% | 556,769 | - |
| 76 | NKTR | Nektar Therapeutics | 2.65B | -0.37% | 774,310 | 55.63M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 2.05% | 1,265,740 | 670.00M |
| 78 | VERA | Vera Therapeutics, Inc. | 2.63B | 0.25% | 663,601 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.62B | -1.17% | 691,811 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 2.59B | -2.59% | 2,313,851 | 415.62M |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 6.85% | 1,136,858 | - |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 0.30% | 682,779 | 535.08M |
| 83 | IMNM | Immunome, Inc. | 2.57B | -1.35% | 1,236,295 | 4.02M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.51B | -0.87% | 773,792 | 865.00K |
| 85 | RLAY | Relay Therapeutics, Inc. | 2.48B | 0.62% | 2,017,512 | 10.68M |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.04% | 726,865 | 225.27M |
| 87 | KOD | Kodiak Sciences Inc. | 2.47B | -0.90% | 407,133 | - |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -1.58% | 426,631 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.31B | -1.12% | 1,013,884 | - |
| 90 | NBTX | Nanobiotix S.A. | 2.29B | -9.92% | 128,405 | 38.27M |
| 91 | ZLAB | Zai Lab Limited | 2.19B | -0.31% | 464,965 | 453.28M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.10B | -0.81% | 1,128,152 | - |
| 93 | TYRA | Tyra Biosciences, Inc. | 2.07B | 2.53% | 471,279 | - |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.72% | 1,335,101 | 298.30M |
| 95 | PHVS | Pharvaris N.V. | 2.04B | 4.34% | 321,671 | - |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.46% | 297,929 | 32.08M |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | -1.39% | 2,830,399 | 2.18B |
| 98 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -1.29% | 3,703,193 | 52.04M |
| 99 | AAPG | Ascentage Pharma Group International | 1.98B | -2.31% | 12,063 | 82.08M |
| 100 | GENB | Generate Biomedicines, Inc. | 1.97B | 7.79% | 292,864 | 30.30M |
| 101 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 0.44% | 1,636,803 | 7.47M |
| 102 | NTLA | Intellia Therapeutics, Inc. | 1.95B | -2.98% | 4,657,997 | 66.09M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.95B | 6.73% | 8,319,395 | 509.86M |
| 104 | ANAB | AnaptysBio, Inc. | 1.89B | -3.45% | 853,939 | 232.39M |
| 105 | MESO | Mesoblast Limited | 1.86B | -0.48% | 144,622 | 65.38M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.85B | -10.90% | 525,215 | - |
| 107 | QURE | uniQure N.V. | 1.84B | 5.28% | 4,094,545 | 18.09M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.19% | 1,057,078 | 11.13M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -4.54% | 1,203,736 | 217.17M |
| 110 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -0.44% | 106,961 | 1.20B |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.80B | 3.03% | 155,329 | - |
| 112 | OCS | Oculis Holding AG | 1.80B | -6.86% | 532,512 | 1.40M |
| 113 | RAPP | Rapport Therapeutics, Inc. | 1.78B | -3.15% | 300,981 | 20.00M |
| 114 | MBX | MBX Biosciences, Inc. | 1.76B | -7.73% | 1,052,653 | - |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -0.10% | 1,043,979 | 899.11M |
| 116 | ZYME | Zymeworks Inc. | 1.75B | -0.54% | 723,952 | 81.26M |
| 117 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -1.98% | 2,450,886 | 70.92M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 1.54% | 766,918 | 66.05M |
| 119 | NUVB | Nuvation Bio Inc. | 1.69B | 1.68% | 2,540,745 | 143.05M |
| 120 | VCEL | Vericel Corporation | 1.68B | 0.06% | 486,683 | 292.09M |
| 121 | INVA | Innoviva, Inc. | 1.68B | 0.98% | 582,016 | 420.69M |
| 122 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | -3.37% | 14,572,495 | 66.41M |
| 123 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -1.97% | 658,728 | 71.78M |
| 124 | ARDX | Ardelyx, Inc. | 1.63B | - | 1,823,000 | 427.68M |
| 125 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -5.68% | 523,146 | 42.95M |
| 126 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | -3.78% | 29,883,263 | 285.61M |
| 127 | INBX | Inhibrx Biosciences, Inc. | 1.59B | -14.84% | 1,273,355 | 1.30M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.59B | 1.18% | 1,235,986 | 65.50M |
| 129 | NVAX | Novavax, Inc. | 1.58B | 1.26% | 6,135,897 | 596.34M |
| 130 | IMTX | Immatics N.V. | 1.53B | -1.30% | 483,102 | 56.67M |
| 131 | ATAI | AtaiBeckley Inc. | 1.52B | 2.72% | 5,166,069 | 4.09M |
| 132 | ABCL | AbCellera Biologics Inc. | 1.51B | -5.71% | 16,942,420 | 79.21M |
| 133 | IMCR | Immunocore Holdings plc | 1.49B | 1.56% | 135,686 | 412.81M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.47B | -2.36% | 352,854 | - |
| 135 | URGN | UroGen Pharma Ltd. | 1.45B | -4.88% | 927,547 | 140.49M |
| 136 | PGEN | Precigen, Inc. | 1.44B | -2.86% | 2,322,181 | 9.68M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.43B | 1.02% | 350,464 | 20.00M |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.07% | 2,247,528 | 73.62M |
| 139 | DMRA | Damora Therapeutics, Inc. | 1.39B | -5.21% | 528,493 | - |
| 140 | BHVN | Biohaven Ltd. | 1.39B | 1.32% | 1,818,594 | - |
| 141 | FTRE | Fortrea Holdings Inc. | 1.38B | -2.54% | 1,339,318 | 2.71B |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.37B | 0.65% | 179,171 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.17% | 412,581 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | 1.01% | 904,284 | - |
| 145 | GHRS | GH Research PLC | 1.34B | 1.32% | 94,963 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.33B | -3.45% | 1,577,479 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.31B | -3.96% | 4,998,664 | 71.80M |
| 148 | SVRA | Savara Inc. | 1.29B | -0.78% | 725,962 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.12% | 308,642 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.25B | 1.49% | 366,720 | - |
| 151 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | -5.99% | 2,603,284 | - |
| 152 | DBVT | DBV Technologies S.A. | 1.21B | -2.06% | 174,566 | 5.74M |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.20B | -1.69% | 2,040,841 | 204.73M |
| 154 | IVA | Inventiva S.A. | 1.20B | -0.86% | 89,174 | 7.94M |
| 155 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | 3.60% | 142,739 | - |
| 156 | EYPT | EyePoint, Inc. | 1.14B | -2.58% | 764,199 | 7.61M |
| 157 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -6.08% | 296,918 | 10.00M |
| 158 | SEPN | Septerna, Inc. | 1.12B | 5.39% | 408,166 | 72.26M |
| 159 | AKTS | Aktis Oncology, Inc. | 1.09B | 7.99% | 149,696 | 8.28M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | 4.33% | 6,253,566 | 69.64M |
| 161 | OMER | Omeros Corporation | 1.07B | 2.79% | 1,099,879 | - |
| 162 | MNKD | MannKind Corporation | 1.01B | -2.38% | 5,514,041 | 360.78M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 995.26M | 2.54% | 1,024,791 | 204.89M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 992.55M | 9.64% | 1,929,514 | - |
| 165 | DSGN | Design Therapeutics, Inc. | 986.20M | 1.15% | 496,920 | - |
| 166 | SLS | SELLAS Life Sciences Group, Inc. | 963.26M | -0.57% | 5,902,700 | - |
| 167 | XNCR | Xencor, Inc. | 922.32M | -2.74% | 664,325 | 97.36M |
| 168 | PHAR | Pharming Group N.V. | 919.15M | 3.69% | 8,201 | 369.49M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 914.06M | -1.78% | 908,082 | - |
| 170 | SANA | Sana Biotechnology, Inc. | 907.23M | -8.43% | 4,527,094 | - |
| 171 | MGTX | MeiraGTx Holdings plc | 906.29M | -1.11% | 359,413 | 81.39M |
| 172 | GERN | Geron Corporation | 898.13M | 0.72% | 26,741,812 | 196.12M |
| 173 | LBRX | LB Pharmaceuticals Inc | 892.67M | -4.80% | 88,980 | - |
| 174 | VOR | Vor Biopharma Inc. | 892.44M | -4.52% | 1,225,089 | - |
| 175 | ANNX | Annexon, Inc. | 891.30M | -4.23% | 1,189,659 | - |
| 176 | JANX | Janux Therapeutics, Inc. | 878.78M | 1.26% | 665,927 | 13.73M |
| 177 | DRTS | Alpha Tau Medical Ltd. | 869.54M | -4.45% | 875,853 | - |
| 178 | ANRO | Alto Neuroscience, Inc. | 863.35M | 0.41% | 206,921 | - |
| 179 | KURA | Kura Oncology, Inc. | 859.22M | 1.79% | 1,840,027 | 71.64M |
| 180 | SPRY | ARS Pharmaceuticals, Inc. | 856.96M | 0.35% | 1,128,632 | 84.28M |
| 181 | TBPH | Theravance Biopharma, Inc. | 849.59M | -0.24% | 272,333 | 109.78M |
| 182 | ABUS | Arbutus Biopharma Corporation | 848.81M | -1.82% | 1,025,849 | 14.08M |
| 183 | SPTX | Seaport Therapeutics, Inc. | 845.79M | 4.89% | 155,042 | - |
| 184 | CTMX | CytomX Therapeutics, Inc. | 844.69M | 0.52% | 1,744,721 | 35.54M |
| 185 | ODTX | Odyssey Therapeutics, Inc. | 844.42M | 2.58% | 171,159 | 2.98M |
| 186 | DRUG | Bright Minds Biosciences Inc. | 836.91M | -2.20% | 126,789 | - |
| 187 | ABSI | Absci Corporation | 834.87M | -7.35% | 4,078,701 | 1.84M |
| 188 | AURA | Aura Biosciences, Inc. | 819.86M | -3.17% | 478,460 | - |
| 189 | EVMN | Evommune, Inc. | 817.26M | -2.24% | 279,213 | 10.00M |
| 190 | SGP | SpyGlass Pharma, Inc. | 806.92M | 1.60% | 42,718 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 793.56M | 0.88% | 10,034,074 | 22.00K |
| 192 | RLMD | Relmada Therapeutics, Inc. | 781.42M | 1.22% | 1,441,978 | - |
| 193 | SLDB | Solid Biosciences Inc. | 759.75M | 0.52% | 1,010,690 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 716.55M | 1.84% | 511,818 | - |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 681.56M | -1.41% | 949,247 | 8.37M |
| 196 | STRO | Sutro Biopharma, Inc. | 677.79M | 4.07% | 224,683 | 102.48M |
| 197 | GYRE | Gyre Therapeutics, Inc. | 667.02M | 2.96% | 50,285 | 117.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 653.22M | 2.31% | 1,122,236 | 122.29M |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 650.67M | 3.04% | 224,457 | - |
| 200 | CADL | Candel Therapeutics, Inc. | 638.92M | -1.47% | 2,830,427 | - |
| 201 | EIKN | Eikon Therapeutics, Inc. | 624.22M | 15.88% | 407,681 | - |
| 202 | KYTX | Kyverna Therapeutics, Inc. | 619.22M | -1.06% | 616,824 | - |
| 203 | TRAX | First Tracks Biotherapeutics, Inc. | 618.88M | -5.06% | 1,004,560 | - |
| 204 | ARVN | Arvinas, Inc. | 617.47M | -0.93% | 1,695,894 | 89.40M |
| 205 | FBRX | Forte Biosciences, Inc. | 616.03M | -6.58% | 262,225 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 613.41M | -0.32% | 297,043 | 11.88M |
| 207 | ALT | Altimmune, Inc. | 598.13M | -0.32% | 2,436,619 | 41.00K |
| 208 | PRME | Prime Medicine, Inc. | 596.04M | 1.85% | 3,057,111 | 4.03M |
| 209 | AGMB | AgomAb Therapeutics NV | 594.92M | -0.82% | 90,390 | - |
| 210 | CABA | Cabaletta Bio, Inc. | 591.87M | -4.97% | 4,022,451 | - |
| 211 | CRMD | CorMedix Inc. | 589.10M | -1.96% | 1,190,624 | 311.71M |
| 212 | IMMX | Immix Biopharma, Inc. | 565.11M | 7.46% | 921,341 | - |
| 213 | VALN | Valneva SE | 562.56M | -4.76% | 74,383 | 205.07M |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 544.81M | -3.81% | 1,320,870 | 151.40M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 543.41M | 12.10% | 1,230,485 | 299.77M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 540.54M | -4.17% | 459,002 | 88.24M |
| 217 | PROK | ProKidney Corp. | 537.49M | 0.56% | 976,806 | 893.00K |
| 218 | CLYM | Climb Bio, Inc. | 533.57M | 0.45% | 310,815 | - |
| 219 | AVTX | Avalo Therapeutics, Inc. | 532.68M | -1.53% | 1,708,740 | 59.00K |
| 220 | RGNX | REGENXBIO Inc. | 528.56M | 1.59% | 1,024,356 | 170.44M |
| 221 | TECX | Tectonic Therapeutic, Inc. | 527.58M | 1.60% | 237,572 | - |
| 222 | MDXG | MiMedx Group, Inc. | 527.27M | -0.56% | 1,422,376 | 389.42M |
| 223 | ANL | Adlai Nortye Ltd. | 526.00M | 1.47% | 133,908 | 5.00M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 510.70M | 0.07% | 126,426 | - |
| 225 | STTK | Shattuck Labs, Inc. | 500.35M | -5.70% | 1,085,574 | 1.00M |
| 226 | OCGN | Ocugen, Inc. | 497.62M | -0.68% | 6,725,167 | 4.47M |
| 227 | XOMA | XOMA Royalty Corporation | 497.48M | 0.70% | 83,679 | 48.56M |
| 228 | OVID | Ovid Therapeutics Inc. | 496.62M | 2.87% | 4,826,566 | 7.25M |
| 229 | PRTA | Prothena Corporation plc | 493.69M | -2.48% | 495,044 | 57.94M |
| 230 | NGNE | Neurogene Inc. | 492.52M | 2.10% | 103,482 | 925.00K |
| 231 | ASMB | Assembly Biosciences, Inc. | 489.81M | 1.35% | 60,753 | 71.10M |
| 232 | UPB | Upstream Bio, Inc. | 487.06M | -1.87% | 467,445 | 2.85M |
| 233 | SGMT | Sagimet Biosciences Inc. | 472.40M | -0.52% | 793,385 | - |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.07M | 2.56% | 114,678 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 466.68M | -3.33% | 309,912 | 12.14M |
| 236 | FULC | Fulcrum Therapeutics, Inc. | 463.77M | -0.57% | 598,664 | 80.00M |
| 237 | ZURA | Zura Bio Limited | 450.68M | - | 509,404 | - |
| 238 | LYEL | Lyell Immunopharma, Inc. | 449.15M | 0.26% | 52,797 | 31.00K |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 447.57M | -6.86% | 1,022,844 | - |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 440.15M | 1.66% | 310,187 | - |
| 241 | ADCT | ADC Therapeutics SA | 436.27M | -1.44% | 1,201,430 | 79.18M |
| 242 | LRMR | Larimar Therapeutics, Inc. | 429.04M | 0.98% | 912,326 | - |
| 243 | AUTL | Autolus Therapeutics plc | 425.83M | 1.27% | 1,094,762 | 75.39M |
| 244 | PRTC | PureTech Health plc | 424.75M | -1.09% | 18,264 | 4.66M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 421.65M | -6.02% | 367,018 | 69.21M |
| 246 | IVVD | Invivyd, Inc. | 421.38M | -1.32% | 1,028,848 | 53.43M |
| 247 | IPSC | Century Therapeutics, Inc. | 413.01M | - | 610,434 | 109.16M |
| 248 | MNPR | Monopar Therapeutics Inc. | 410.97M | -6.36% | 152,272 | - |
| 249 | VSTM | Verastem, Inc. | 406.85M | -5.12% | 2,272,733 | 49.59M |
| 250 | BNTC | Benitec Biopharma Inc. | 405.58M | -1.99% | 91,822 | - |
| 251 | VTVT | vTv Therapeutics Inc. | 398.47M | 5.42% | 24,847 | 17.00K |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 397.46M | 1.39% | 1,996,948 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 394.59M | -3.56% | 401,007 | 9.01M |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 386.07M | 2.39% | 1,278,377 | 217.78M |
| 255 | NAUT | Nautilus Biotechnology, Inc. | 372.34M | -2.98% | 252,163 | - |
| 256 | IRD | Opus Genetics, Inc. | 369.86M | 1.17% | 1,659,832 | 14.20M |
| 257 | YDES | YD Bio Limited | 364.96M | -2.26% | 1,307 | 510.36K |
| 258 | PBYI | Puma Biotechnology, Inc. | 360.37M | -0.84% | 346,951 | 227.18M |
| 259 | SRZN | Surrozen, Inc. | 352.18M | 4.71% | 84,673 | 7.49M |
| 260 | CCCC | C4 Therapeutics, Inc. | 349.27M | - | 2,314,816 | 35.95M |
| 261 | NMRA | Neumora Therapeutics, Inc. | 347.11M | 1.60% | 821,918 | - |
| 262 | RZLT | Rezolute, Inc. | 342.78M | 4.10% | 1,341,591 | - |
| 263 | GLSI | Greenwich LifeSciences, Inc. | 342.35M | 2.40% | 96,184 | - |
| 264 | DMAC | DiaMedica Therapeutics Inc. | 341.08M | -1.86% | 185,456 | - |
| 265 | REPL | Replimune Group, Inc. | 337.72M | 9.36% | 9,625,041 | - |
| 266 | CMPX | Compass Therapeutics, Inc. | 336.76M | 2.19% | 5,213,525 | 850.00K |
| 267 | IMRX | Immuneering Corporation | 335.13M | -0.38% | 536,712 | - |
| 268 | LCTX | Lineage Cell Therapeutics, Inc. | 331.57M | 1.53% | 1,714,382 | 14.56M |
| 269 | ARMP | Armata Pharmaceuticals, Inc. | 330.26M | 2.04% | 68,660 | 4.90M |
| 270 | BCYC | Bicycle Therapeutics plc | 329.02M | 0.43% | 218,839 | 63.50M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 327.21M | -5.42% | 592,495 | 1.00 |
| 272 | ABEO | Abeona Therapeutics Inc. | 323.09M | -3.07% | 1,282,339 | 5.82M |
| 273 | PALI | Palisade Bio, Inc. | 321.45M | -1.03% | 1,808,463 | - |
| 274 | SLN | Silence Therapeutics plc | 320.72M | -5.30% | 289,083 | 839.00K |
| 275 | ACHV | Achieve Life Sciences, Inc. | 318.91M | 7.16% | 2,832,202 | - |
| 276 | NAGE | Niagen Bioscience, Inc. | 307.27M | -3.27% | 1,211,320 | 130.42M |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 304.68M | 3.38% | 435,620 | 26.87M |
| 278 | NGEN | NervGen Pharma Corp. | 301.87M | -2.61% | 68,036 | - |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 301.48M | 2.09% | 1,330,215 | - |
| 280 | CLLS | Cellectis S.A. | 292.27M | 0.50% | 24,087 | 75.11M |
| 281 | NVCT | Nuvectis Pharma, Inc. | 289.13M | -1.45% | 96,084 | - |
| 282 | EDIT | Editas Medicine, Inc. | 286.87M | -4.25% | 1,020,939 | 38.69M |
| 283 | AVXL | Anavex Life Sciences Corp. | 283.58M | -5.56% | 1,235,979 | - |
| 284 | TARA | Protara Therapeutics, Inc. | 283.56M | -2.28% | 419,482 | - |
| 285 | ACIU | AC Immune SA | 274.79M | -2.12% | 446,352 | 4.62M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 273.16M | -2.40% | 595,764 | - |
| 287 | OABI | OmniAb, Inc. | 268.20M | 10.78% | 956,159 | 28.94M |
| 288 | CGEN | Compugen Ltd. | 267.59M | -1.39% | 323,867 | 72.76M |
| 289 | CHRS | Coherus Oncology, Inc. | 263.71M | -12.31% | 3,463,734 | 46.88M |
| 290 | ARTV | Artiva Biotherapeutics, Inc. | 262.74M | 0.28% | 528,843 | 251.00K |
| 291 | FATE | Fate Therapeutics, Inc. | 261.63M | 3.21% | 2,130,083 | 6.65M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 258.50M | - | 1,403,250 | 1.55M |
| 293 | TRDA | Entrada Therapeutics, Inc. | 256.56M | 1.71% | 1,239,193 | 5.74M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 255.62M | 1.99% | 107,211 | 1.78M |
| 295 | SABS | SAB Biotherapeutics, Inc. | 254.40M | -2.69% | 837,021 | 114.70K |
| 296 | HELP | Cybin Inc. | 253.18M | -0.78% | 484,075 | - |
| 297 | VYGR | Voyager Therapeutics, Inc. | 250.75M | 0.73% | 477,271 | 36.49M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 248.95M | -2.08% | 183,775 | 28.22M |
| 299 | LENZ | LENZ Therapeutics, Inc. | 248.01M | -20.82% | 2,346,583 | 20.99M |
| 300 | NERV | Minerva Neurosciences, Inc. | 245.52M | -0.53% | 79,979 | - |
| 301 | FENC | Fennec Pharmaceuticals Inc. | 244.03M | -0.99% | 114,123 | 44.64M |
| 302 | OBIO | Orchestra BioMed Holdings, Inc. | 243.12M | 3.84% | 137,923 | 33.48M |
| 303 | ADAG | Adagene Inc. | 241.83M | -3.43% | 30,863 | 7.67M |
| 304 | ALEC | Alector, Inc. | 239.81M | 5.37% | 437,289 | 18.42M |
| 305 | NBP | NovaBridge Biosciences | 238.24M | -1.90% | 502,035 | - |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 234.49M | -4.51% | 689,429 | 54.71M |
| 307 | NKTX | Nkarta, Inc. | 233.83M | 3.14% | 500,694 | - |
| 308 | CAMP | Camp4 Therapeutics Corporation | 233.67M | 2.27% | 146,900 | 3.93M |
| 309 | CDXS | Codexis, Inc. | 230.88M | -4.15% | 938,909 | 78.09M |
| 310 | KROS | Keros Therapeutics, Inc. | 230.53M | -3.00% | 343,512 | 244.06M |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 228.01M | -0.33% | 22,007 | 19.39M |
| 312 | CNTX | Context Therapeutics Inc. | 227.86M | 3.77% | 308,781 | - |
| 313 | MGNX | MacroGenics, Inc. | 223.73M | 19.32% | 9,609,972 | 149.50M |
| 314 | UNCY | Unicycive Therapeutics, Inc. | 218.14M | 2.77% | 421,714 | - |
| 315 | TNYA | Tenaya Therapeutics, Inc. | 217.00M | 0.19% | 9,925,428 | 225.00K |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.69M | -5.88% | 532,574 | 17.56M |
| 317 | DTIL | Precision BioSciences, Inc. | 211.59M | 4.33% | 203,608 | 45.07M |
| 318 | MDWD | MediWound Ltd. | 207.31M | -2.00% | 74,224 | 16.96M |
| 319 | RNA | Atrium Therapeutics, Inc. | 203.87M | -0.83% | 178,787 | 18.62M |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 202.73M | 3.53% | 262,907 | - |
| 321 | HUMA | Humacyte, Inc. | 202.04M | -9.00% | 4,690,104 | 2.04M |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 200.97M | 1.19% | 275,362 | 146.07M |
| 323 | CRBU | Caribou Biosciences, Inc. | 199.47M | - | 1,762,425 | 11.20M |
| 324 | TLSA | Tiziana Life Sciences Ltd | 199.09M | 1.96% | 75,112 | - |
| 325 | ELTX | Elicio Therapeutics, Inc. | 194.08M | -9.13% | 197,783 | - |
| 326 | WHWK | Whitehawk Therapeutics, Inc. | 193.76M | 3.16% | 56,549 | 7.15M |
| 327 | CNTN | Canton Strategic Holdings, Inc. | 185.27M | 2.51% | 323,403 | - |
| 328 | HRTX | Heron Therapeutics, Inc. | 182.50M | 0.93% | 2,364,908 | 150.71M |
| 329 | ENLV | Enlivex Ltd. | 180.62M | 0.82% | 180,568 | - |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 179.99M | -3.68% | 156,420 | 2.00M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 179.12M | -3.50% | 250,210 | - |
| 332 | IFRX | InflaRx N.V. | 175.67M | -2.80% | 2,290,507 | 33.82K |
| 333 | PRQR | ProQR Therapeutics N.V. | 168.58M | -0.62% | 303,467 | 19.19M |
| 334 | PYXS | Pyxis Oncology, Inc. | 163.42M | -5.45% | 390,040 | 13.86M |
| 335 | KZIA | Kazia Therapeutics Limited | 163.40M | 1.42% | 100,924 | 1.27M |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 162.16M | -3.74% | 669,105 | 70.00M |
| 337 | IMUX | Immunic, Inc. | 162.10M | -0.83% | 155,039 | - |
| 338 | KRRO | Korro Bio, Inc. | 161.82M | -2.09% | 118,092 | 3.84M |
| 339 | MENS | Jyong Biotech Ltd. | 160.72M | 0.97% | 22,387 | - |
| 340 | PLYX | Polaryx Therapeutics, Inc. | 155.29M | -3.24% | 181,286 | - |
| 341 | PLX | Protalix BioTherapeutics, Inc. | 153.89M | -1.55% | 590,907 | 52.74M |
| 342 | HURA | TuHURA Biosciences, Inc. | 153.86M | 0.83% | 446,378 | - |
| 343 | ANTX | AN2 Therapeutics, Inc. | 153.70M | -9.53% | 189,026 | - |
| 344 | SPRB | Spruce Biosciences, Inc. | 153.12M | 0.47% | 36,248 | 697.00K |
| 345 | CNTB | Connect Biopharma Holdings Limited | 151.48M | 14.53% | 233,794 | 64.00K |
| 346 | MOLN | Molecular Partners AG | 150.18M | -2.18% | 5,478 | 856.30K |
| 347 | GALT | Galectin Therapeutics Inc. | 148.11M | 1.81% | 279,261 | - |
| 348 | SPRO | Spero Therapeutics, Inc. | 147.07M | -0.39% | 350,889 | 66.80M |
| 349 | EQ | Equillium, Inc. | 143.52M | 0.89% | 98,287 | 4.39M |
| 350 | AGEN | Agenus Inc. | 142.89M | 5.52% | 799,546 | 123.87M |
| 351 | ALPS | Alps Group Inc | 139.36M | 0.90% | 13,756 | 3.74M |
| 352 | NTHI | NeOnc Technologies Holdings, Inc. | 138.79M | 0.18% | 71,811 | 39.99K |
| 353 | IPHA | Innate Pharma S.A. | 137.51M | -4.23% | 3,193 | 10.57M |
| 354 | OKUR | OnKure Therapeutics, Inc. | 136.94M | -1.45% | 112,987 | - |
| 355 | AARD | Aardvark Therapeutics, Inc. | 133.30M | 6.82% | 181,877 | - |
| 356 | GNLX | Genelux Corporation | 131.89M | 2.41% | 137,072 | 8.00K |
| 357 | VRCA | Verrica Pharmaceuticals Inc. | 122.83M | -3.38% | 36,616 | 35.58M |
| 358 | ACOG | Alpha Cognition Inc. | 119.54M | -7.73% | 59,924 | 10.22M |
| 359 | TTRX | Turn Therapeutics Inc. | 118.56M | 2.58% | 32,313 | - |
| 360 | EDSA | Edesa Biotech, Inc. | 117.91M | -13.15% | 454,600 | - |
| 361 | GUTS | Fractyl Health, Inc. | 116.45M | -4.55% | 2,187,334 | 3.00K |
| 362 | PEPG | PepGen Inc. | 116.20M | -1.18% | 903,405 | - |
| 363 | INO | Inovio Pharmaceuticals, Inc. | 115.53M | -1.40% | 2,997,172 | 65.34K |
| 364 | BMEA | Biomea Fusion, Inc. | 114.23M | 0.64% | 585,138 | - |
| 365 | CRDF | Cardiff Oncology, Inc. | 112.13M | 0.61% | 614,880 | 593.00K |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 109.90M | 1.06% | 163,023 | - |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 109.79M | 2.80% | 1,111,652 | 1.63M |
| 368 | CBUS | Cibus, Inc. | 109.08M | 3.62% | 105,535 | 3.64M |
| 369 | CGTX | Cognition Therapeutics, Inc. | 105.44M | - | 678,608 | - |
| 370 | ONCY | Oncolytics Biotech Inc. | 104.90M | -0.03% | 575,725 | - |
| 371 | ALDX | Aldeyra Therapeutics, Inc. | 103.15M | -2.84% | 718,553 | - |
| 372 | SEER | Seer, Inc. | 102.69M | -0.55% | 248,984 | 16.58M |
| 373 | COYA | Coya Therapeutics, Inc. | 100.63M | 2.63% | 512,519 | 7.95M |
| 374 | ANIX | Anixa Biosciences, Inc. | 98.91M | -2.64% | 109,293 | - |
| 375 | QTTB | Q32 Bio Inc. | 98.52M | 12.16% | 644,532 | 53.74M |
| 376 | VANI | Vivani Medical, Inc. | 98.31M | -5.00% | 200,355 | - |
| 377 | ENGN | enGene Therapeutics Inc. | 96.46M | -3.36% | 4,347,714 | - |
| 378 | LONA | LeonaBio, Inc. | 95.53M | 1.60% | 28,189 | - |
| 379 | CUE | Cue Biopharma, Inc. | 95.25M | -6.58% | 157,805 | 27.47M |
| 380 | NRXS | NeurAxis, Inc. | 95.15M | 1.47% | 183,497 | 3.57M |
| 381 | NRXP | NRx Pharmaceuticals, Inc. | 94.81M | 1.77% | 721,937 | 1.23M |
| 382 | PMN | ProMIS Neurosciences, Inc. | 94.07M | -1.78% | 24,701 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 91.40M | 1.45% | 8,632 | 16.80M |
| 384 | RNTX | Rein Therapeutics Inc. | 87.40M | -2.61% | 303,292 | - |
| 385 | CSBR | Champions Oncology, Inc. | 87.07M | 4.33% | 8,738 | 57.95M |
| 386 | PYPD | PolyPid Ltd. | 87.02M | 5.07% | 108,368 | - |
| 387 | OKYO | OKYO Pharma Limited | 85.02M | -1.82% | 51,328 | - |
| 388 | EXOZ | eXoZymes, Inc. | 83.77M | 0.82% | 969 | -700.00 |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 83.51M | 11.73% | 1,084,504 | 120.77M |
| 390 | ACET | Adicet Bio, Inc. | 83.48M | -2.69% | 63,827 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 80.89M | -1.05% | 274,707 | - |
| 392 | GOSS | Gossamer Bio, Inc. | 79.94M | 0.56% | 2,684,631 | 48.47M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 79.48M | - | 737,674 | - |
| 394 | ANVS | Annovis Bio, Inc. | 78.73M | -4.60% | 679,281 | - |
| 395 | ATHE | Alterity Therapeutics Limited | 78.51M | 0.63% | 11,291 | 4.43M |
| 396 | GANX | Gain Therapeutics, Inc. | 76.78M | -1.10% | 358,728 | - |
| 397 | MCRB | Seres Therapeutics, Inc. | 76.67M | 1.53% | 23,997 | 1.15M |
| 398 | XBIT | XBiotech Inc. | 76.22M | 1.21% | 30,652 | - |
| 399 | ICCC | ImmuCell Corporation | 75.81M | -0.83% | 9,732 | 27.64M |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 75.73M | 2.16% | 1,438,846 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 75.08M | 0.89% | 129,077 | 63.26M |
| 402 | RLYB | Rallybio Corporation | 74.21M | 0.21% | 87,739 | 858.00K |
| 403 | PLRX | Pliant Therapeutics, Inc. | 73.06M | -1.67% | 269,369 | - |
| 404 | OSTX | OS Therapies Incorporated | 71.89M | - | 226,587 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 69.12M | -2.54% | 894,222 | 9.14M |
| 406 | ACTU | Actuate Therapeutics, Inc. | 68.53M | -2.86% | 122,572 | - |
| 407 | MNOV | MediciNova, Inc. | 67.93M | -1.77% | 28,976 | 409.66K |
| 408 | IBO | Impact BioMedical Inc. | 67.39M | - | 47,872 | 32.00K |
| 409 | IMA | ImageneBio, Inc. | 63.98M | 1.96% | 11,297 | 800.00K |
| 410 | HYFT | MindWalk Holdings Corp. | 63.57M | -3.03% | 104,012 | 20.70M |
| 411 | IMMP | Immutep Limited | 62.77M | 6.12% | 1,242,695 | 5.28M |
| 412 | PDSB | PDS Biotechnology Corporation | 61.40M | -15.38% | 1,804,790 | - |
| 413 | LIXT | Lixte Biotechnology Holdings, Inc. | 58.90M | -1.55% | 40,460 | - |
| 414 | CING | Cingulate Inc. | 58.68M | -3.43% | 408,450 | - |
| 415 | ENTX | Entera Bio Ltd. | 58.28M | 6.84% | 108,842 | 42.00K |
| 416 | IBIO | iBio, Inc. | 58.19M | -3.01% | 396,731 | 300.00K |
| 417 | KALA | KALA BIO, Inc. | 58.00M | -20.20% | 168,604 | - |
| 418 | FLNA | Filana Therapeutics, Inc. | 57.97M | -6.25% | 480,087 | - |
| 419 | BYSI | BeyondSpring Inc. | 57.16M | -8.55% | 5,466 | 1.88M |
| 420 | INKT | MiNK Therapeutics, Inc. | 56.84M | 4.20% | 29,789 | - |
| 421 | DWTX | Dogwood Therapeutics, Inc. | 56.78M | 0.59% | 92,734 | - |
| 422 | TIL | Instil Bio, Inc. | 54.93M | -0.37% | 10,661 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 54.45M | 1.10% | - | - |
| 424 | ATYR | aTyr Pharma, Inc. | 51.99M | -44.20% | 12,306,880 | 190.00K |
| 425 | ESLA | Estrella Immunopharma, Inc. | 51.62M | -3.97% | 8,869 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 50.82M | - | 189,518 | 22.33M |
| 427 | HYPD | Hyperion DeFi, Inc. | 48.73M | -5.51% | 365,384 | 813.46K |
| 428 | XLO | Xilio Therapeutics, Inc. | 46.25M | - | 25,592 | 43.77M |
| 429 | RADX | Radiopharm Theranostics Limited | 46.05M | 4.00% | 75,655 | 10.86M |
| 430 | LITS | Lite Strategy, Inc. | 45.45M | 0.81% | 285,244 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 44.43M | -6.18% | 60,136 | - |
| 432 | NTRB | Nutriband Inc. | 44.37M | - | 8,149 | 2.04M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | -2.33% | 80,763 | - |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 40.53M | -2.99% | 139,062 | 90.00K |
| 435 | PSTV | Plus Therapeutics, Inc. | 40.14M | -3.15% | 92,797 | 5.21M |
| 436 | ALGS | Aligos Therapeutics, Inc. | 40.04M | 4.19% | 94,946 | 4.71M |
| 437 | RNXT | RenovoRx, Inc. | 39.32M | 2.68% | 126,689 | 1.12M |
| 438 | MREO | Mereo BioPharma Group plc | 39.27M | 1.44% | 2,548,290 | 500.00K |
| 439 | DARE | Daré Bioscience, Inc. | 38.29M | 4.37% | 625,204 | 1.03M |
| 440 | PTN | Palatin Technologies, Inc. | 38.00M | 3.71% | 5,686 | 8.96M |
| 441 | TVRD | Tvardi Therapeutics, Inc. | 37.34M | 0.51% | 27,425 | - |
| 442 | INMB | INmune Bio Inc. | 36.95M | 2.96% | 346,962 | 50.00K |
| 443 | VERU | Veru Inc. | 36.43M | 2.71% | 57,642 | 16.89M |
| 444 | GRCE | Grace Therapeutics, Inc. | 36.05M | -0.85% | 220,236 | - |
| 445 | PLUR | Pluri Inc. | 35.58M | 0.57% | 26,243 | 1.34M |
| 446 | NXTC | NextCure, Inc. | 35.28M | - | 3,915 | - |
| 447 | CRVO | CervoMed Inc. | 34.91M | -0.79% | 34,075 | 4.01M |
| 448 | EVAX | Evaxion A/S | 34.78M | -1.30% | 29,403 | 7.53M |
| 449 | BOLD | Boundless Bio, Inc. | 33.63M | -3.23% | 261,915 | - |
| 450 | NNVC | NanoViricides, Inc. | 32.39M | 0.67% | 305,439 | - |
| 451 | APLM | Apollomics, Inc. | 32.17M | - | 15,980 | 8.84M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 30.71M | -4.31% | 561,723 | 1.14M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 30.21M | -4.90% | 157,039 | 22.00K |
| 454 | QNTM | Quantum BioPharma Ltd. | 30.12M | 2.77% | 121,341 | - |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.48M | -1.92% | 85,412 | - |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 29.45M | -0.24% | 42,282 | - |
| 457 | LSTA | Lisata Therapeutics, Inc. | 29.45M | - | 18,016 | 170.00K |
| 458 | IGC | IGC Pharma, Inc. | 29.29M | -2.15% | 379,007 | 1.11M |
| 459 | KYNB | Kyntra Bio, Inc. | 29.25M | 6.25% | 12,912 | 7.44M |
| 460 | TVGN | Tevogen Bio Holdings Inc. | 29.02M | -0.43% | 68,088 | - |
| 461 | SKYE | Skye Bioscience, Inc. | 28.58M | -7.56% | 118,873 | - |
| 462 | SNSE | Sensei Biotherapeutics, Inc. | 28.15M | 1.30% | 28,423 | - |
| 463 | PLRZ | Polyrizon Ltd. | 28.10M | -6.89% | 32,964 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 27.78M | -0.72% | 13,340 | 14.97M |
| 465 | TPST | Tempest Therapeutics, Inc. | 27.54M | -1.03% | 61,148 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 26.95M | -3.29% | 35,319 | 14.99M |
| 467 | DYAI | Dyadic International, Inc. | 26.34M | -0.19% | 43,279 | 3.09M |
| 468 | ABVC | ABVC BioPharma, Inc. | 25.95M | 2.94% | 79,207 | 797.92K |
| 469 | JSPR | Jasper Therapeutics, Inc. | 25.55M | -3.15% | 205,770 | - |
| 470 | OTLK | Outlook Therapeutics, Inc. | 25.37M | -2.10% | 2,209,520 | 205.70K |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 24.63M | -7.72% | 6,365,797 | 789.00K |
| 472 | SER | Serina Therapeutics, Inc. | 24.28M | 1.87% | 86,168 | 130.00K |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.01M | -0.69% | 51,097 | 3.55M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 23.50M | -9.52% | 368,444 | 320.00K |
| 475 | AEON | AEON Biopharma, Inc. | 23.15M | -0.23% | 15,344 | - |
| 476 | LTRN | Lantern Pharma Inc. | 23.09M | -1.44% | 151,760 | - |
| 477 | CELU | Celularity Inc. | 22.39M | 0.84% | 65,649 | 26.55M |
| 478 | CRIS | Curis, Inc. | 22.00M | -0.11% | 295,592 | 9.44M |
| 479 | VYNE | VYNE Therapeutics Inc. | 21.99M | -0.69% | 139,593 | 570.00K |
| 480 | LGVN | Longeveron Inc. | 21.96M | -10.48% | 572,790 | 1.20M |
| 481 | OSRH | OSR Holdings, Inc. | 21.27M | 13.09% | 2,787,247 | 2.91M |
| 482 | GRDX | GridAI Technologies Corp. | 20.77M | 5.02% | 93,590 | - |
| 483 | XCUR | Exicure, Inc. | 20.65M | -4.14% | 8,128 | 500.00K |
| 484 | QNCX | Quince Therapeutics, Inc. | 20.54M | 1.61% | 632,966 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 19.46M | -1.40% | 50,442 | - |
| 486 | ICU | SeaStar Medical Holding Corporation | 19.35M | 5.68% | 77,051 | 1.23M |
| 487 | LPCN | Lipocine Inc. | 18.70M | 0.43% | 115,987 | 2.00M |
| 488 | COCP | Cocrystal Pharma, Inc. | 18.06M | 0.77% | 127,894 | - |
| 489 | NCEL | NewcelX Ltd. | 17.93M | -0.60% | 14,119 | - |
| 490 | TRAW | Traws Pharma, Inc. | 17.06M | -16.83% | 2,718,641 | 2.79M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.62M | -4.01% | 708,091 | 3.94M |
| 492 | PASG | Passage Bio, Inc. | 16.14M | 14.32% | 159,604 | - |
| 493 | CVKD | Cadrenal Therapeutics, Inc. | 15.98M | -5.98% | 48,852 | - |
| 494 | INAB | IN8bio, Inc. | 15.76M | -1.54% | 40,213 | - |
| 495 | TOVX | Theriva Biologics, Inc. | 14.77M | -5.60% | 2,138,508 | 300.00K |
| 496 | GNTA | Genenta Science S.p.A. | 14.46M | -2.65% | 24,451 | - |
| 497 | LEXX | Lexaria Bioscience Corp. | 14.30M | -4.63% | 305,340 | 368.00K |
| 498 | ERNA | Ernexa Therapeutics Inc. | 14.01M | 66.57% | 19,408,159 | 1,000.00 |
| 499 | HIND | Vyome Holdings, Inc. | 13.90M | 0.51% | 253,923 | 319.71K |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.44M | -0.31% | 55,503 | 2.07M |